C. Prakash Gyawali MD, MRCPProfessor of Medicine, Director of Neurogastroenterology and Motility, and Program Director of Gastroenterology Fellowship Training, Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri
Dr. Prakash Gyawali is currently a Professor of Medicine, Director of Neurogastroenterology and Motility, and Program Director of Gastroenterology Fellowship Training at the Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri, USA. Dr. Gyawali's academic interests include gastrointestinal motility, gastroesophageal reflux disease, and functional bowel disorders; he is also prominently involved in education and mentoring of students, residents, fellows and peers at all levels. He directs gastrointestinal motility centers affiliated with Washington University, and is involved in motility testing using high resolution manometry, esophageal ambulatory esophageal pH and impedance monitoring, wireless pH monitoring and endoscopic functional lumen imaging probe. He is part of several working groups and consensus committees involving esophageal physiologic testing, and has over 175 original publications. He has an extensive academic practice in esophagology and functional bowel disorders, and is actively involved in clinical research involving neurogastroenterology and motility.
DisclosuresDr. Gyawali is a consultant and speaker for Medtronic and Diversatek and is a consultant for Ironwood, Torax, Quintiles, and Isothrive.
Recent Contributions to PracticeUpdate:
- Functional Dyspepsia and Gastroparesis in Tertiary Care Are Interchangeable Syndromes
- Efficacy and Safety of Tradipitant for Patients With Diabetic and Idiopathic Gastroparesis
- Achalasia Subtypes Can Be Identified With FLIP Panometry Using a Supervised Machine Learning Process
- Prevalence of Rome IV Functional Bowel Disorders Among Adults in the US, Canada, and the UK
- Distinct Physiological Characteristics of Isolated Laryngopharyngeal Reflux Symptoms
- Prucalopride in Gastroparesis
- Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome
- Scintigraphy Demonstrates High Rate of False-Positive Results From Glucose Breath Tests for Small Bowel Bacterial Overgrowth